RXRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

36.52

Margin Of Safety %

Put/Call OI Ratio

0.23

EPS Next Q Diff

-0.01

EPS Last/This Y

0.52

EPS This/Next Y

0.04

Price

3.01

Target Price

6.64

Analyst Recom

2.25

Performance Q

-11.73

Upside

-618.3%

Beta

1.02

Ticker: RXRX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	RXRX	3.51	0.26	0.12	353828
2026-04-24	RXRX	3.52	0.26	0.04	354779
2026-04-27	RXRX	3.48	0.27	0.06	350352
2026-04-28	RXRX	3.41	0.27	0.35	350870
2026-04-29	RXRX	3.31	0.27	0.42	352585
2026-04-30	RXRX	3.46	0.27	0.06	356402
2026-05-01	RXRX	3.38	0.27	0.05	359454
2026-05-04	RXRX	3.52	0.26	0.21	363285
2026-05-05	RXRX	3.38	0.26	0.76	369123
2026-05-06	RXRX	3.43	0.27	0.10	375152
2026-05-07	RXRX	3.28	0.27	0.09	372939
2026-05-08	RXRX	3.32	0.27	0.10	374063
2026-05-11	RXRX	3.27	0.27	0.04	356166
2026-05-12	RXRX	3.14	0.26	0.21	367090
2026-05-13	RXRX	3.05	0.26	0.18	369295
2026-05-14	RXRX	3.04	0.27	0.10	372264
2026-05-15	RXRX	2.92	0.26	0.21	374655
2026-05-18	RXRX	2.89	0.23	0.20	330660
2026-05-19	RXRX	2.86	0.23	0.17	333953
2026-05-20	RXRX	2.95	0.23	0.10	335189
2026-05-21	RXRX	3.12	0.23	0.07	337587
2026-05-22	RXRX	3.01	0.23	0.29	340214
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	RXRX	3.51	50.0	-	-0.95
2026-04-24	RXRX	3.51	50.0	-	-0.95
2026-04-27	RXRX	3.49	50.0	-	-0.95
2026-04-28	RXRX	3.41	50.0	-	-0.95
2026-04-30	RXRX	3.46	50.0	-	-0.95
2026-05-01	RXRX	3.38	50.0	-	-0.95
2026-05-04	RXRX	3.52	48.5	-	-1.01
2026-05-05	RXRX	3.38	48.5	-	-1.01
2026-05-06	RXRX	3.44	48.5	-	-1.01
2026-05-07	RXRX	3.27	48.6	-	-1.01
2026-05-08	RXRX	3.33	48.6	-	-0.90
2026-05-11	RXRX	3.27	45.4	-	-0.90
2026-05-12	RXRX	3.14	45.3	-	-0.90
2026-05-13	RXRX	3.05	43.5	-	-0.90
2026-05-14	RXRX	3.03	43.5	-	-0.90
2026-05-15	RXRX	2.92	43.5	-	-0.93
2026-05-18	RXRX	2.89	43.5	-	-0.93
2026-05-19	RXRX	2.86	43.5	-	-0.93
2026-05-20	RXRX	2.95	43.5	-	-0.93
2026-05-21	RXRX	3.11	43.5	-	-0.93
2026-05-22	RXRX	3.01	43.5	-	-0.92
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	RXRX	-2.42	2.50	37.27
2026-04-24	RXRX	-2.52	2.50	37.27
2026-04-27	RXRX	-2.37	2.45	37.37
2026-04-28	RXRX	-2.37	2.45	37.37
2026-04-29	RXRX	-2.37	2.45	37.37
2026-04-30	RXRX	-2.37	2.45	37.37
2026-05-01	RXRX	-2.37	2.45	37.37
2026-05-04	RXRX	-2.37	0.54	37.37
2026-05-05	RXRX	-2.37	0.54	37.37
2026-05-06	RXRX	-2.37	0.54	37.37
2026-05-07	RXRX	-2.31	0.54	37.37
2026-05-08	RXRX	-2.35	0.54	37.37
2026-05-11	RXRX	-2.41	0.57	37.18
2026-05-12	RXRX	-2.41	0.57	36.52
2026-05-13	RXRX	-2.41	0.57	36.52
2026-05-14	RXRX	-2.41	0.57	36.52
2026-05-15	RXRX	-2.41	0.57	36.52
2026-05-18	RXRX	-2.41	-0.14	36.52
2026-05-19	RXRX	-2.41	-0.14	36.52
2026-05-20	RXRX	-2.35	-0.14	36.52
2026-05-21	RXRX	-2.35	-0.14	36.52
2026-05-22	RXRX	-2.35	-0.14	36.52
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.22

Avg. EPS Est. Current Quarter

-0.23

Avg. EPS Est. Next Quarter

-0.23

Insider Transactions

-2.35

Institutional Transactions

-0.14

Beta

1.02

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-93.1

Target Price

6.64

P/E

Forward P/E

PEG

P/S

24.06

P/B

1.56

P/Free Cash Flow

EPS

-1.2

Average EPS Est. Cur. Y

-0.92

EPS Next Y. (Est.)

-0.88

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-842.93

Relative Volume

1.01

Return on Equity vs Sector %

-81.7

Return on Equity vs Industry %

-66.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

◆ RXRX Healthcare

$3.01

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

19/25

Volume

4/15

Valuation

12/20

TP/AR

1/10

Options

8/10

RSI

Range 1M

24.5%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

15/30

Estimates

1/20

Inst/Vol

1/15

Options

8/10

EPS Yr

35.9%

EPS NY

5.3%

52W%

5.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +120.6% upside

Quality

2/30

Valuation

16/30

Growth

14/25

Stability

6/10

LT Trend

1/5

Upside

+120.6%

Quality

Recursion Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 600

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

RXRX

Latest News

—

Caricamento notizie per RXRX…

stock quote shares RXRX – Recursion Pharmaceuticals, Inc. Stock Price stock today

news today RXRX – Recursion Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch RXRX – Recursion Pharmaceuticals, Inc. yahoo finance google finance

stock history RXRX – Recursion Pharmaceuticals, Inc. invest stock market

stock prices RXRX premarket after hours

ticker RXRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RXRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y